21st Century Cures Act to be signed by President
Thursday, December 8, 2016
Virginia Biotechnology Association CEO Jeff Gallagher issued the following statement regarding passage of the 21st Century Cures Act by the U.S. Senate:
“This important and much-anticipated legislation provides new funding to the National Institutes of Health (NIH) (including for the BRAIN Initiative, the Precision Medicine Initiative and Cancer Moonshot) and the Food and Drug Administration (FDA), and funds to fight the opioid epidemic. It also brings helpful modernization to clinical trials, and puts patients more centrally in the regulatory review process.”
21st Century Cures is legislation that accelerates the cycle of discovering, developing, and delivery new cures. The bill provides the opportunity to help researchers change the way they fight disease.
To learn more about the 21st Century Cures Act, visit these website:
Energy & Commerce Committee
BIO's Letter of support